Company / Interest Expense per Share
Vistagen Therapeutics, Inc. Interest Expense per Share History
FY2011-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2021
5-year range
$0.00 / $0.49
FY2017-FY2021
Trend
-21.7%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.49 to $0.00 over the past 4 years.
Based on SEC 10-K filings.
0.00 in FY2021 with a 10-year CAGR of -49.0%.
Improved from $0.49 to $0.00 over the past 4 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -7.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -49.0%
Key checks
Key Insights
- In FY2021, interest expense per share decreased 21.7% year-over-year.
- Peak interest expense per share was recorded in FY2011.
- Lowest interest expense per share in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.00 | -21.7% |
| FY2018 | $0.00 | -99.8% |
| FY2017 | $0.49 | +1072.1% |
| FY2014 | -$0.05 | +70.2% |
| FY2012 | -$0.17 | -128.6% |
| FY2011 | $0.60 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026